Aprea therapeutics stock

Aprea therapeutics stock

What is the stock price of APRE Therapeutics? According to the World Health Organization (WHO), Aprea Therapeutics shares traded on March 11, 2020, when the coronavirus reached pandemic status. Since then, APRE shares have fallen and are now trading at USD. See which stocks have been most affected by COVID19.

Who is aprea therapeutics and what do they do for dogs

Aprea Therapeutics, Inc. is a Boston, Massachusetts-based biopharmaceutical company with research centers in Stockholm, Sweden, that develops and commercializes novel cancer treatments that reactivate the mutated tumor suppressor protein p53.

What is the hold rating on APRE Therapeutics?

Wall Street analysts agree that investors should own shares of Aprea Therapeutics. The custody letter states that analysts believe that investors should maintain their existing holdings in APRE, but not buy additional shares or sell existing shares.

Who are the institutional investors in APRE Therapeutics?

During the last quarter, APRE shares were bought by several institutional investors, including Kennedy Capital Management Inc., PDT Partners LLC, Susquehanna International Group LLP, JPMorgan Chase & Co., Millennium Management LLC, Morgan Stanley, Morgan Stanley and Simplex Trading.

Who is aprea therapeutics and what do they do for people

On average, they expect Aprea Therapeutics' stock price to hit the dollar next year. This suggests the stock may be trending downward relative to the price targets set by analysts at Aprea Therapeutics or the high-value stocks of analysts on Wall Street.

What are the ratings on APRE Therapeutics stock?

The stock currently has 2 sales ratings and 4 retention ratings. Wall Street analysts agree that investors should own shares of Aprea Therapeutics.

What is the short interest in APRE Therapeutics?

With an average daily trading volume of 3,470,000 shares, short-term interest is currently in days. The shares are sold short. See Aprea Therapeutics brief interest.

:diamond_shape_with_a_dot_inside: What was the IPO price for APRE Therapeutics?

(APRE) raised $52 million in an initial public offering (IPO) on Thursday, October 3, 2019. The company has issued 5,000,000 shares at a price of US$ per share. Underwriters for the IPO were Morgan, Morgan Stanley and RBC Capital Markets. What is the stock symbol for Aprea Therapeutics?

Who is aprea therapeutics and what do they do for work

Aprea Therapeutics is a biotechnology company specializing in the discovery and development of cancer drugs. They focus on developing those that can reactivate the p53 protein, a tumor suppressor.

What are the analyst ratings for Aprea Therapeutics?

Based on 6 analyst ratings over the past year, the consensus forecast for Aprea Therapeutics Hold is based on 2 current sales ratings and 4 holding ratings for APRE. The 12-month average price target for Aprea Therapeutics is $ with $ high target and $ low target.

Is there a clinical hold on Aprea Therapeutics?

The FDA has suspended the investigation of Aprea's lymphoid malignancy following the introduction of a partial clinical suspension of the Aprea Therapeutics Incs (NASDAQ: APRE) program for myeloid malignancies.

:brown_circle: What is the market capitalization of Aprea Therapeutics?

Aprea Therapeutics has a market cap of millions of dollars. The company has $53,480 a year in net income (earnings) or ($), depending on earnings per share. How many employees does Aprea Therapeutics have?

:eight_spoked_asterisk: What qualifies as an institutional investor?

An institutional investor is a company that raises money to buy stocks, real estate and other assets or to make loans. Institutional investors include banks, insurance companies, retirement plans, hedge funds, REITs, investment advisors, mutual funds and mutual funds.

:eight_spoked_asterisk: What entity is considered an institutional investor?

Definition of Institutional Investors.

:eight_spoked_asterisk: Who are in these institutional investors?

Institutional investors include public and private pension funds, insurance companies, savings banks, public and private investment companies, funds and foundations. Institutional investors invest these assets in different categories.

:diamond_shape_with_a_dot_inside: What does it mean for institutional investors?

An institutional investor is a company or organization that invests on behalf of others. Some examples are investment funds, pension funds and insurance companies.

:eight_spoked_asterisk: What are institutional investment firms?

Institutional investors. Investment organizations, including insurance companies, custodians, pension funds, investment companies, mutual funds and mutual funds. A company that owns and manages assets for both its customers and itself.

:diamond_shape_with_a_dot_inside: What is institutional investors

In other words, an institutional investor is an organization that invests on behalf of its members. Institutional investors are legal entities that trade on financial markets.